Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
CALL
UnitedHealth
UNH
$358B
| $9.89M | 0.01% |
40,000
+25,000
| +167% | +$6.38M |
|
|
1252
PUT
UnitedHealth
UNH
$358B
| $9.89M | 0.01% |
+40,000
| New | +$10.2M |
|
|
AJRD
1253
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $9.87M | 0.01% |
277,792
-154,783
| -36% | -$5.7M |
|
1254
Gentex
GNTX
$4.97B
| $9.87M | 0.01% |
477,048
+302,948
| +174% | +$6.33M |
|
1255
Allison Transmission
ALSN
$10.8B
| $9.83M | 0.01% |
218,924
+187,012
| +586% | +$8.88M |
|
1256
Stride
LRN
$3.54B
| $9.83M | 0.01% |
288,100
-248,557
| -46% | -$7.58M |
|
1257
HEICO Corp Class A
HEI.A
$36.2B
| $9.83M | 0.01% |
116,949
-263,496
| -69% | -$19.3M |
|
1258
CALL
Masco
MAS
$14.4B
| $9.83M | 0.01% |
250,000
| – | – |
|
1259
Macerich
MAC
$6.91B
| $9.83M | 0.01% |
226,658
-18,663
| -8% | -$825K |
|
1260
Tetra Tech
TTEK
$9.44B
| $9.81M | 0.01% |
823,530
-688,170
| -46% | -$7.72M |
|
1261
Conduent
CNDT
$250M
| $9.81M | 0.01% |
709,015
-11,291
| -2% | -$150K |
|
1262
PUT
Oracle
ORCL
$410B
| $9.79M | 0.01% |
182,300
+81,700
| +81% | +$4.16M |
|
|
WCC
1263
WESCO International
WCC
$16.4B
| $9.79M | 0.01% |
184,585
-69,849
| -27% | -$3.69M |
|
1264
Trex
TREX
$4.82B
| $9.78M | 0.01% |
318,000
-136,914
| -30% | -$4.78M |
|
|
HNGR
1265
DELISTED
Hanger Inc.
HNGR
| $9.76M | 0.01% |
512,480
+425,833
| +491% | +$8.44M |
|
1266
NIO
NIO
$10.9B
| $9.76M | 0.01% |
1,913,267
+1,529,267
| +398% | +$10.8M |
|
|
BRSL
1267
Brightstar Lottery PLC
BRSL
$2.16B
| $9.75M | 0.01% |
750,840
-694,404
| -48% | -$10.7M |
|
|
HTO
1268
H2O America
HTO
$2.7B
| $9.74M | 0.01% |
157,811
-69,657
| -31% | -$4.18M |
|
|
EGRX
1269
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9.74M | 0.01% |
192,948
-91,805
| -32% | -$4.09M |
|
1270
Unifirst Corp
UNF
$5.28B
| $9.74M | 0.01% |
63,452
+52,412
| +475% | +$7.37M |
|
1271
Interparfums
IPAR
$3.74B
| $9.73M | 0.01% |
128,317
+89,528
| +231% | +$6.27M |
|
|
KDMN
1272
DELISTED
Kadmon Holdings, Inc.
KDMN
| $9.71M | 0.01% |
3,678,811
+3,259,154
| +777% | +$8.22M |
|
1273
Southside Bancshares
SBSI
$956M
| $9.69M | 0.01% |
291,506
+162,879
| +127% | +$5.52M |
|
|
MZTI
1274
The Marzetti Company
MZTI
$3.17B
| $9.68M | 0.01% |
+61,801
| New | +$9.94M |
|
1275
Insmed
INSM
$27.1B
| $9.66M | 0.01% |
332,268
+321,153
| +2,889% | +$8.32M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.